Has John Law, MD received payments from drug or device companies?

Yes. Drug and device makers reported $34,860 in general payments to John Law, MD across 899 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Law, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Law, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Law, MD

Family Medicine · Farragut, TNNPI 1740259761

Payments from drug & device makers

$34,860in general payments, 2019–2025

Across 899 payments — averaging $38.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Gilead$22K
AbbVie$2K
Novo Nordisk$1K
Pfizer$1K
Lilly USA, LLC$743
AstraZeneca$680
plus $7K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Gilead	60	$21,946
AbbVie(2 entities)	129	$1,672
Novo Nordisk	97	$1,331
Pfizer	92	$1,155
Lilly USA, LLC	52	$743
AstraZeneca	35	$680
Amgen(2 entities)	49	$677
Boehringer Ingelheim	41	$618
Abbott	29	$469
Merck	33	$414
GSK	23	$377
Amarin Pharma, Inc.	23	$349
Otsuka America Pharmaceutical, Inc.	19	$329
Lundbeck LLC	14	$306
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	14	$270
Viiv Healthcare Company	12	$236
Astellas Pharma US Inc	8	$234
Sanofi-aventis U.S. LLC	13	$216
Johnson & Johnson	6	$186
Novartis	10	$175
Bayer	11	$170
Takeda Pharmaceuticals U.S.A., Inc.	12	$161
Silk Road Medical, Inc.	1	$147
Eisai Inc.	8	$129
Shield Therapeutics Inc	7	$116
Theratechnologies Inc.	5	$114
Antares Pharma, Inc.	7	$112
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	6	$91
Boston Scientific	4	$88
Jazz Pharmaceuticals Inc.	4	$88
Axsome Therapeutics, Inc.	5	$87
E.r. Squibb & Sons, L.L.C.	5	$85
Medtronic(2 entities)	4	$76
Exact Sciences	5	$75
Vanda Pharmaceuticals Inc.	2	$67
Azurity Pharmaceuticals, Inc.	4	$66
Biohaven Pharmaceutical Holding Company Ltd.	4	$66
Adlon Therapeutics L.p.	4	$64
Esperion Therapeutics, Inc.	3	$51
Arbor Pharmaceuticals, Inc.	3	$49
Teva Pharmaceuticals USA, Inc.	3	$47
Kowa Pharmaceuticals America, Inc.	3	$41
Verona Pharma, Inc.	2	$41
Biohaven Pharmaceuticals, Inc.	2	$37
Nevro Corp.	2	$36
Dexcom, Inc.	2	$30
Dynavax Technologies Corporation	2	$30
Shire North American Group Inc	2	$29
VBI Vaccine (delaware) Inc.	2	$28
Daiichi Sankyo Inc.	2	$27
Genentech USA, Inc.	1	$23
Tris Pharma Inc	1	$22
Seqirus USA Inc	1	$20
Philips North America LLC	1	$20
Kyowa Kirin, Inc.	1	$19
Phadia US Inc.	1	$17
Supernus Pharmaceuticals, Inc.	1	$17
Halozyme Inc	1	$16
Xeris Pharmaceuticals, Inc.	1	$15
Nabriva Therapeutics, PLC	1	$14

How this compares

$34,860 in reported general payments places this provider in the 95th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee →

Medicare billing

Part B allowed, 2024

$74,778

Medicare patients

131

Services billed

10,000

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Farragut

Richard MattisonFarragut$31K
Rickey ManningKnoxville$8.1M
Kymberly MoyerGallatin$5.9M
Natasha BallardChattanooga$5.7M
Hina BudhwaniNashville$4.7M
Paul WakefieldKnoxville$4.3M
Emily HubbsKingsport$2.8M
Jerry PunchKnoxville$2.1M
Bridgette FraneyNashville$2M
Andrew BrockmyreBristol$1.8M

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →